AbCellera Biologics Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
ABCL on Nasdaq
Industry
Pharmaceutical Preparations
Location
150 W 4 Th Avenue, Vancouver, British Columbia, Canada

Insiders trading volume in the past year

AbCellera Biologics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
L. Hansen Carl Chief Executive Officer, Director, 10%+ Owner $272M Jan 1, 2025
Thermopylae Holdings Ltd. 10%+ Owner $121M +$1.48M +1.24% Mar 11, 2025
Andrew Booth Chief Financial Officer $92.4M Jan 1, 2025
Veronique Lecault Chief Operating Officer, Director $61.5M Jan 1, 2025
Tryn Stimart Chief Legal Officer $45.9M Jan 1, 2025
John Hamer Director $39.8M Aug 31, 2021
Ester Falconer Chief Technology Officer $14.6M Sep 23, 2021
Michael R. Hayden Director $10.9M Jun 21, 2024
John S. Montalbano Director $9.2M +$198K +2.2% Mar 10, 2025
Andrew Lo Director $1.94M Jun 21, 2024
DCVC Bio, L.P. 10%+ Owner $200K Jun 18, 2021

Recent Insider Transactions by Companies or Individuals for AbCellera Biologics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.